Salubris Pharmaceuticals Co.,Ltd.

Salubris Pharmaceuticals Co.,Ltd. company information, Employees & Contact Information

Explore related pages

Salubris Pharmaceuticals Co.,Ltd. email format Salubris Pharmaceuticals Co.,Ltd. management contacts

Related company profiles:

Salubris is a global integrated pharmaceutical group dedicated to the research, development, manufacture, marketing, distribution, and service of professional pharmaceutical and healthcare products to bring healthier and happier life to people worldwide through world-leading quality and innovations. Shenzhen Salubris Pharmaceuticals Co., Ltd. is a professional pharmaceutical enterprise rooted in China and devoted to improving health worldwide. The company focuses on the newest generation of innovative and specialty medicine, and is an international organization possessing and continuously developing state-of-the-art technologies and products, and has been recognized as an advanced technology enterprise and innovative high-tech company. The company has a team of high-caliber management, R&D, and marketing professionals. It has nationally approved modern GMP pharmaceutical manufacturing facilities, advanced equipment s and testing instruments, producing tablet, capsule, and injection formulations and active pharmaceutical ingredients, with subsidiary branches and marketing network throughout the country.

Company Details

Employees
452
Address
37f, Tower B, Neo Building, No.6009 Shennan Road, Futian District,shenzhen,guangdong 518040,china
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
salubris.cn
Keywords
RX for Cardiovascular, Interventional medical device, antibiotics, Bio-pharmaceutical.
HQ
Futian District, Shenzhen, Guangdong
Competitors
Shanghai Allist Pharmaceuticals Co., Ltd, Fosun Pharma, Lindy Biosciences, Inc., HAYA Therapeutics, Shenzhen Salubris Pharmaceuticals Co., Ltd, Jacobio Pharma, Addex Therapeutics, Quotient Therapeutics, Salubris Biotherapeutics, YolTech Therapeutics.
Looking for a particular Salubris Pharmaceuticals Co.,Ltd. employee's phone or email?

Salubris Pharmaceuticals Co.,ltd. Questions

News

Salubris Biotherapeutics Provides Updates on JK07 and JK06 Clinical Programs - Business Wire

Salubris Biotherapeutics Provides Updates on JK07 and JK06 Clinical Programs Business Wire

Interim data success for Salubris Biotherapeutics’ heart failure candidate - Clinical Trials Arena

Interim data success for Salubris Biotherapeutics’ heart failure candidate Clinical Trials Arena

Shenzhen Salubris Pharmaceuticals discovers new tertiary amine compounds - BioWorld MedTech

Shenzhen Salubris Pharmaceuticals discovers new tertiary amine compounds BioWorld MedTech

Salubris Biotherapeutics Announces Positive Interim Data from the Phase 2 Trial of JK07 in Heart Failure - Business Wire

Salubris Biotherapeutics Announces Positive Interim Data from the Phase 2 Trial of JK07 in Heart Failure Business Wire

YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M - Fierce Biotech

YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M Fierce Biotech

Salubris Biotherapeutics Appoints Arian Pano, M.D., as Chief Medical Officer - citybiz

Salubris Biotherapeutics Appoints Arian Pano, M.D., as Chief Medical Officer citybiz

Carlyle Buys Stake in Chinese Health-Care Firm for $260 Million - Bloomberg

Carlyle Buys Stake in Chinese Health-Care Firm for $260 Million Bloomberg

Salubris reports positive results from Phase Ib trial of HFrEF therapy - Clinical Trials Arena

Salubris reports positive results from Phase Ib trial of HFrEF therapy Clinical Trials Arena

Salubris Biotherapeutics Announces Dose Escalation Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the European Society for Medical Oncology 2025 Congress - FinancialContent

Salubris Biotherapeutics Announces Dose Escalation Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the European Society for Medical Oncology 2025 Congress FinancialContent

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 54.68 - Markets Mojo

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 54.68 Markets Mojo

Salubris Plans to Acquire Stake in Swiss Cardiovascular Interventional Therapy Equipment Developer - 一财全球Yicai Global

Salubris Plans to Acquire Stake in Swiss Cardiovascular Interventional Therapy Equipment Developer 一财全球Yicai Global

Yoltech licenses gene editing therapy to Salubris for $145M - BioWorld MedTech

Yoltech licenses gene editing therapy to Salubris for $145M BioWorld MedTech

Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update - Business Wire

Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update Business Wire

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 52.94 - Markets Mojo

Shenzhen Salubris Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 52.94 Markets Mojo

User - FinancialContent

User FinancialContent

Salubris Biotherapeutics Announces European Medicines Agency Approval to Initiate a Phase 1 Clinical Trial of JK06, a 5T4-Targeted ADC, in Solid Tumors - Business Wire

Salubris Biotherapeutics Announces European Medicines Agency Approval to Initiate a Phase 1 Clinical Trial of JK06, a 5T4-Targeted ADC, in Solid Tumors Business Wire

D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China - Business Wire

D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China Business Wire

Shenzhen Salubris Pharma's unit to acquire Salubris Biotherapeutics Inc in U.S. - Reuters

Shenzhen Salubris Pharma's unit to acquire Salubris Biotherapeutics Inc in U.S. Reuters

Salubris Pharma Buys Into Viracta, Eyes Exclusive License for Cancer Treatment - 一财全球Yicai Global

Salubris Pharma Buys Into Viracta, Eyes Exclusive License for Cancer Treatment 一财全球Yicai Global

The sexy gum: a love story - The Conversation

The sexy gum: a love story The Conversation

Rigg and Grylls carbon credit play inks deal, shelves IPO - The West Australian

Rigg and Grylls carbon credit play inks deal, shelves IPO The West Australian

Residents pitch in to build state-of-the-art hospital - Rappler

Residents pitch in to build state-of-the-art hospital Rappler

Companies like Salubris Pharmaceuticals Co.,Ltd.

HAYA Therapeutics logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Haya Therapeutics

57
Addex Therapeutics logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Addex Therapeutics

22
Lindy Biosciences, Inc. logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Lindy Biosciences, Inc.

20
Shenzhen Salubris Pharmaceuticals Co., Ltd logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Shenzhen Salubris Ph...

28
Quotient Therapeutics logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Quotient Therapeutics

78
Fosun Pharma logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Fosun Pharma

4.97K
Jacobio Pharma logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Jacobio Pharma

40
Salubris Biotherapeutics logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Salubris Biotherapeu...

36
Shanghai Allist Pharmaceuticals Co., Ltd logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Shanghai Allist Phar...

30
YolTech Therapeutics logo - Similar company to Salubris Pharmaceuticals Co.,Ltd.

Yoltech Therapeutics

10

Top Salubris Pharmaceuticals Co.,Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant